 Home > Biochemistry News > Biotechnology News > AstraZeneca terminates DNA HPV cancer vaccine cooperation agreement

AstraZeneca terminates DNA HPV cancer vaccine cooperation agreement

 Last Update: 2021-11-14
 Source: Internet
 Author: User

Tags

2d rubik's cube

cancer cell international

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Article source: Medical Rubik's Cube Info

Author: Shi Bei

On October 28, MedImmune, AstraZeneca's global biologics R&D department, issued a notice to Inovio that the development plan of INO-3112/MEDI0457 had been terminated
.

Inovio and MedImmune signed this DNA cancer vaccine cooperation agreement on August 7, 2015

According to the previous agreement, MedImmune obtained the exclusive right of Inovio's INO-3112 immunotherapy and changed its name to MEDI0457
.

At the same time, MedImmune has the right to sublicense the therapy

The cooperation agreement allows MedImmune to terminate the agreement on a project-by-project, product-by-product, and/or country-by-country basis at any time
.

After the termination of the cooperation, Inovio will regain the rights of INO-3112 and will no longer obtain potential future milestone payments or royalties under the cooperation agreement

MedImmune is currently conducting a phase II clinical trial for head and neck squamous cell carcinoma (HNSCC).
The primary endpoint data collection of the trial has been completed and the clinical study report is planned to be completed by the end of 2022
.

MedImmune will continue to sponsor this research until the end of the research

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.